This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Member Connect   Tech Transfer   Events   Publications   Marketplace
                
Apr. 5, 2012
 
 
 



Big-Picture Thinker
Priestly Medalist Robert Langer's Entrepreneurial Streak Traces Back to His Dream of Improving People's Lives

Chemical and Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
"Anybody can get lucky once," says John T. Santini Jr., a former graduate student of Robert S. Langer's and a cofounder with Langer of the company MicroCHIPS. "It's a little harder to get lucky 25 times." Langer, 63, has shown time and again that he's no one-hit wonder. This serial entrepreneur has cofounded about 25 companies and licensed technology to scores more. All that commercialization is in service of his primary goal-making sure his inventions help improve health. More




Sustainable: New Biodegradable Plastic Bag is in the Works
Finance & Commerce    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An Arkansas-based startup is hoping to turn a technology that originated at the University of Minnesota into a widely accepted alternative to plastic bags. The bags, under development by Fayetteville, AR-based cycleWood Solutions, would be made from a material called lignin, which cycleWood claims is biodegradable within 150 days. Lignin exists in all plant life and is a largely discarded waste product from the biofuels and papermaking industries. Although brittle in its raw form, cycleWood says it can be made into a material that is as thin and malleable as plastic derived from petroleum. More

Eisai, University of Kansas Grant Water-Soluble Pro-Drug Technology Patent to OneWorld Health
The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
OneWorld Health (OWH), a nonprofit that develops lifesaving medicines for neglected diseases, announced that it has signed a nonexclusive patent agreement with Eisai Co., Ltd., for a water-soluble pro-drug technology patent. OWH will use the pro-drug technology to advance development of iOWH032, its new drug to treat acute secretory diarrhea. The original water-soluble pro-drug technology was developed by scientists at the University of Kansas (KU), and the exclusive patent right is owned by the KU Center for Technology Commercialization, Inc. (KUCTC). KUCTC licensed the patent to Eisai, and both parties generously agreed to Eisai sublicensing the rights to OWH. More




MD Anderson, Rice Share Cancer Drug Commercialization Grant
Houston Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The state cancer program has given two Houston academic institutions a $20 million grant to accelerate the availability of life-saving treatments. The grant, to be shared by the University of Texas M.D. Anderson Cancer Center and Rice University, is part of the Cancer Prevention & Research Institute of Texas' increasing emphasis on commercialization, much needed in a state where biotechnology efforts lag considerably behind the research activity. More

Nanotech-Based Solar Cell Research
Solar Novus Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In pursuit of "futuristic technologies using earth abundant, non-toxic materials," researchers at the State University of New York at Binghamton, Binghamton, New York (US), for the first time achieved zinc phosphide nanowire formation at a temperature of only 350 degrees Celsius. "At the Center for Autonomous Solar Power at Binghamton University, we are aiming for large-scale penetration of solar power," says Parag Vasekar, Ph.D., research scientist at the Center. He also thinks these novel cells should be manufactured using least energy intensive fabrication technologies and be easy to apply to flexible substrates over a large area. Needless to add, the scientist wants to see his research become reality "in the near future and at a low cost." More

New Blindness Treatment Envisioned by MUSC Spinoff; MitoChem Raises $2M
MedCity News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A Medical University of South Carolina (MUSC) spinoff researching a treatment for degenerative retinal conditions such as macular degeneration is closing in on a drug candidate that could slow vision loss or even restore some lost vision. MitoChem has received a $2 million financial commitment from the nonprofit Foundation Fighting Blindness to select the best candidate from three compounds. Charleston, South Carolina-based MitoChem had previously screened a library of 50,000 compounds to narrow its choices to the three compounds with vision-saving properties. More

Create Large Format Posters Easily
With large format printers
and design templates from Océ, quickly create and print professional color posters
and teaching aids whenever you need them – and less expensively than outsourcing! Océ color printers are versatile, easy to use and offer a variety of print/copy/scan technologies to satisfy most every requirement.
more


Universities Hail Budget's Research Pledge
The Globe and Mail    Share    Share on FacebookTwitterShare on LinkedinE-mail article
University leaders are rejoicing at the federal budget's research and innovation measures, which they see signaling that the government has understood the need to back a strong research culture even in hard times. In a budget of deep cuts, university presidents were happy and relieved to see funding levels for basic research maintained alongside new investments to link schools more closely with industry. More

Researchers Close in On Vaccine to Protect Babies
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at the University of Saskatchewan are closing in on a needle-free vaccine for respiratory syncytial virus (RSV), a major cause of respiratory illness in children under two years of age. Sylvia van den Hurk and her team have developed a vaccine candidate that shows promise against RSV, with human clinical trials about two years away. "It's one of the most important respiratory infections in young babies. And there's no vaccine," van den Hurk says. More

OSU Creates Spot to Spawn Startup Ideas
The Columbus Dispatch    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Ohio State University is opening a $2 million center on High Street where researchers and students can meet with entrepreneurs to come up with ways to turn their research into moneymaking products and jobs. Like the campuses of Apple, Google and Microsoft, the new headquarters of OSU’s Office of Technology Commercialization and Knowledge Transfer, set to open Thursday, is designed to foster a culture of people working hard — and having fun — together. Visitors to the storefront office at South Campus Gateway will be greeted by video kiosks featuring breakthrough discoveries in agriculture, bioengineering, medicine and other areas. Lime-green decor and funky, retro furniture brighten the renovated former grocery store. Light bulbs hang from the ceiling to symbolize "bright ideas." More



AUTM 2013 Annual Meeting Call for Topics — Submit Today!
AUTM    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The AUTM 2013 Annual Meeting Call for Topics is open. Submit your idea today.
Deadline to submit: April 16, 2012.
More

Explore Asia with AUTM
AUTM    Share    Share on FacebookTwitterShare on LinkedinE-mail article
AUTM-Asia 2012 (InnovFest), April 18-20, Singapore, is an exciting festival of innovation-related activities. Organized by NUS Enterprise for the third year running, this event aims to boost technology transfer, entrepreneurship and investment among Asia's business, academic and technology communities. More




Voice Analysis Aims to Spot Phone Scams (PhysOrg.com)

FramergyTM to Partner with the Space Alliance Technology Outreach Program (EurekAlert)

Writing Graphene Circuitry with Ion 'Pens' (e Science News)

Researcher's Microdissection Device Hits the Market to Fight Cancer (HealthCanal.com)

 


 
AUTM Newsbrief
Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Hailey Sasser, Senior Content Editor, 469.420.2630

Contribute news
This edition of the AUTM Newsbrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
March 29, 2012
March 22, 2012
March 15, 2012
March 8, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063